-
'Dancing in their hands': Japan wig masters set stage alive
-
Climate scrubbed from G7 meeting to appease US, host France says
-
Trump, his 'low IQ' slur, and the right's race obsession
-
Chip giant SK hynix posts record quarterly profit on AI boom
-
Tesla reports higher profits, confirms hefty spending ahead
-
'Big loss' for F1 if Verstappen quits, say McLaren rivals
-
Israeli strikes kill 5 in Lebanon, Beirut to seek truce extension
-
Barca edge Celta but lose match-winner Yamal to injury
-
UK, France agree three-year deal to stop migrant crossings
-
Trump looks for way out on war, but Iran may not oblige
-
Tears and smiles at tribute concert for Swiss fire victims
-
Tesla reports higher profits, topping estimates
-
Manchester City go top of Premier League as Burnley relegated
-
Kane and Diaz send Bayern past Leverkusen into German Cup final
-
Concert pays tribute to Swiss fire disaster victims
-
US stocks rise, shrugging off uncertain ceasefire prospects while oil prices jump
-
Pope hits out at jails in closed-off Equatorial Guinea
-
Atletico beaten again in Elche thriller
-
England rugby great Moody offered 'hope' in battle with motor neurone disease
-
PSG roll over Nantes to move closer to Ligue 1 title
-
Ecuador doctors protest crisis as patients bring own meds to surgery
-
Top Peru ministers quit in protest over stalled US fighter jet deal
-
De La Hoya and Ali's grandson slam proposed federal boxing reform
-
Archer, Burger turn up the heat as Rajasthan beat Lucknow in IPL
-
Trump alleges Democratic-backed Virginia referendum was 'rigged'
-
Archer, Burger help Rajasthan beat Lucknow in IPL
-
Migrants deported from US stranded, 'scared' in DR Congo
-
Raiders expected to make Mendoza first pick in NFL Draft
-
Chelsea sack Rosenior after worst run since 1912
-
Veteran Fijian Botia extends La Rochelle contract to 2027
-
Colombia's ambitious energy transition gets reality check
-
Liam Rosenior sacked as Chelsea manager
-
'Seriously fractured'? Scepticism over Trump's Iran leadership split claim
-
US doesn't dictate terms of trade talks: Carney
-
Mideast war weighs on parent of Durex condoms
-
Greek parliament lifts immunity of MPs probed in EU farm scandal
-
Just a little late: Frankfurt celebrates new airport terminal
-
Germany forward Gnabry confirms he will miss World Cup
-
Liam Rosenior sacked as Chelsea manager: club
-
Shifting goals blur picture of US blockade on Iran
-
US Treasury chief defends pivot to extend Russia oil sanctions relief
-
French teenager Seixas becomes youngest Fleche Wallonne winner
-
New drugs raise hopes of pancreatic cancer breakthrough
-
South Africa coal delay could cause 32,000 deaths, report says
-
French teenager Seixas becomes youngest winner of La Fleche Wallonne
-
Hezbollah supporters defiant after sons killed fighting Israel
-
EU unblocks 90-bn-euro Ukraine loan after Hungary row
-
Russia says will halt flow of Kazakh oil to Germany
-
Merz says climate policy must not 'endanger' German industry
-
Ziggy Stardust lives on at David Bowie London immersive
Musk's Neuralink says cleared for human test of brain implants
Elon Musk's start-up Neuralink on Thursday said it has gotten approval from US regulators to test its brain implants in people.
Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.
"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter.
"This is the result of incredible work by the Neuralink team in close collaboration with the FDA."
Recruitment for a clinical trial is not yet open, according to Neuralink.
The aim of Neuralink implants is to enable human brains to communicate directly with computers, Musk said during a presentation by the start-up in December.
"We've been working hard to be ready for our first human (implant), and obviously we want to be extremely careful and certain that it will work well before putting a device in a human," he said at the time.
Musk -- who bought Twitter late last year and also owns SpaceX, Tesla and several other companies -- has been known to make ambitious predictions about his companies, with several such forecasts ultimately failing to pan out.
In July 2019, he vowed that Neuralink would be able to perform its first tests on humans in 2020.
Product prototypes, which are the size of a coin, have been implanted in the skulls of monkeys, demonstrations by the startup showed.
At the Neuralink presentation, the company showed several monkeys "playing" basic video games or moving a cursor on a screen through their Neuralink implant.
Musk said the company would try to use the implants to restore vision and mobility in humans who had lost such abilities.
"We would initially enable someone who has almost no ability to operate their muscles... and enable them to operate their phone faster than someone who has working hands," he said.
"As miraculous as it may sound, we are confident that it is possible to restore full body functionality to someone who has a severed spinal cord," he said.
Beyond the potential to treat neurological diseases, Musk's ultimate goal is to ensure that humans are not intellectually overwhelmed by artificial intelligence, he said.
Other companies working on similar systems include Synchron, which announced in July that it had implanted the first brain-machine interface in the United States.
Y.AlMasri--SF-PST